Correlation Between BioForce Nanosciences and Arcadia Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioForce Nanosciences and Arcadia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioForce Nanosciences and Arcadia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioForce Nanosciences Holdings and Arcadia Biosciences, you can compare the effects of market volatilities on BioForce Nanosciences and Arcadia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioForce Nanosciences with a short position of Arcadia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioForce Nanosciences and Arcadia Biosciences.

Diversification Opportunities for BioForce Nanosciences and Arcadia Biosciences

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioForce and Arcadia is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding BioForce Nanosciences Holdings and Arcadia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcadia Biosciences and BioForce Nanosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioForce Nanosciences Holdings are associated (or correlated) with Arcadia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcadia Biosciences has no effect on the direction of BioForce Nanosciences i.e., BioForce Nanosciences and Arcadia Biosciences go up and down completely randomly.

Pair Corralation between BioForce Nanosciences and Arcadia Biosciences

Given the investment horizon of 90 days BioForce Nanosciences Holdings is expected to under-perform the Arcadia Biosciences. But the pink sheet apears to be less risky and, when comparing its historical volatility, BioForce Nanosciences Holdings is 1.18 times less risky than Arcadia Biosciences. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Arcadia Biosciences is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  302.00  in Arcadia Biosciences on September 30, 2024 and sell it today you would earn a total of  309.00  from holding Arcadia Biosciences or generate 102.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BioForce Nanosciences Holdings  vs.  Arcadia Biosciences

 Performance 
       Timeline  
BioForce Nanosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioForce Nanosciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Arcadia Biosciences 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Arcadia Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile fundamental indicators, Arcadia Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

BioForce Nanosciences and Arcadia Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioForce Nanosciences and Arcadia Biosciences

The main advantage of trading using opposite BioForce Nanosciences and Arcadia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioForce Nanosciences position performs unexpectedly, Arcadia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcadia Biosciences will offset losses from the drop in Arcadia Biosciences' long position.
The idea behind BioForce Nanosciences Holdings and Arcadia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals